Multiparametric Renal Magnetic Resonance Imaging for Prediction and Annual Monitoring of the Progression of Chronic Kidney Disease over Two Years

被引:0
|
作者
Buchanan, Charlotte E. [1 ]
Mahmoud, Huda [2 ,3 ]
Cox, Eleanor F. [1 ,4 ,5 ]
Prestwich, Benjamin L. [1 ]
Noble, Rebecca A. [2 ]
Selby, Nicholas M. [2 ]
Taal, Maarten W. [2 ]
Francis, Susan T. [1 ,4 ,5 ]
机构
[1] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Sch Phys & Astron, Nottingham NG7 2RD, England
[2] Univ Nottingham, Ctr Kidney Res & Innovat, Royal Derby Hosp Campus, Derby DE2 3DT, England
[3] Manor Hosp, Walsall Healthcare NHS Trust, Moat Rd, Walsall WS2 9PS, England
[4] Nottingham Univ Hosp NHS Trust, NIHR Nottingham Biomed Res Ctr, Nottingham NG7 2QW, England
[5] Univ Nottingham, Nottingham NG7 2QW, England
基金
英国医学研究理事会;
关键词
chronic kidney disease; magnetic resonance imaging; multiparametric; progression; monitoring; INTRARENAL OXYGENATION; GFR DECLINE; END-POINT; FIBROSIS; PATHOLOGY; EQUATION; CKD;
D O I
10.3390/jcm12237282
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Multiparametric renal Magnetic Resonance Imaging (MRI) provides a non-invasive method to assess kidney structure and function, but longitudinal studies are limited. Methods: A total of 22 patients with CKD category G3-4 (estimated glomerular filtration rate (eGFR) 15-59 mL/min/1.73 m(2)) were recruited. Annual 3T multiparametric renal MRI scans were performed, comprising total kidney volume (TKV), longitudinal relaxation time (T-1), apparent diffusion coefficient (ADC), Arterial Spin Labelling, and Blood Oxygen Level Dependent relaxation time (T-2*), with 15 patients completing a Year 2 scan. CKD progression over 2 years was defined as eGFR_slope >= -5 mL/min/1.73 m(2)/year. Results: At baseline, T-1 was higher (cortex p = 0.05, medulla p = 0.03) and cortex perfusion lower (p = 0.015) in participants with subsequent progression versus stable eGFR. A significant decrease in TKV and ADC and an increase in cortex T-1 occurred in progressors at Year 1 and Year 2, with a significant decrease in perfusion in progressors only at Year 2. The only decline in the stable group was a reduction in TKV. There was no significant change in cortex or medulla T-2* at Year 1 or Year 2 for progressors or stable participants. Conclusion: Lower renal cortex perfusion and higher T-1 in the cortex and medulla may predict CKD progression, while renal cortex T-1, TKV, and ADC may be useful to monitor progression. This study provides pilot data for future large-scale studies.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Kidney Transplantation Multiparametric Functional Magnetic Resonance Imaging for Assessment of Renal Allograft Pathophysiology in Mice
    Hueper, Katja
    Hensen, Bennet
    Gutberlet, Marcel
    Chen, Rongjun
    Hartung, Dagmar
    Barrmeyer, Amelie
    Meier, Martin
    Li, Wang
    Jang, Mi-Sun
    Mengel, Michael
    Wacker, Frank
    Rong, Song
    Gueler, Faikah
    INVESTIGATIVE RADIOLOGY, 2016, 51 (01) : 58 - 65
  • [22] Cardiac Magnetic Resonance Imaging of the Myocardium in Chronic Kidney Disease
    Kis, Eva
    Ablonczy, Laszlo
    Reusz, Gyorgy S.
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (01): : 134 - 142
  • [23] Prediction of Alzheimer's Disease Progression Based on Magnetic Resonance Imaging
    Zhou, Ying
    Song, Zeyu
    Han, Xiao
    Li, Hanjun
    Tang, Xiaoying
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (22): : 4209 - 4223
  • [24] Non-Contrast Renal Magnetic Resonance Imaging to Assess Perfusion and Corticomedullary Differentiation in Health and Chronic Kidney Disease
    Gillis, Keith A.
    McComb, Christie
    Patel, Rajan K.
    Stevens, Kathryn K.
    Schneider, Markus P.
    Radjenovic, Aleksandra
    Morris, Scott T. W.
    Roditi, Giles H.
    Delles, Christian
    Mark, Patrick B.
    NEPHRON, 2016, 133 (03) : 183 - 192
  • [25] Diffusion Weighted Magnetic Resonance Imaging in the Assessment of Renal Function and Parenchymal Changes in Chronic Kidney Disease: A Preliminary Study
    Sulkowska, Katarzyna
    Palczewski, Piotr
    Furmanczyk-Zawiska, Agnieszka
    Perkowska-Ptasinska, Agnieszka
    Wojcik, Damian
    Szeszkowski, Wojciech
    Durlik, Magdalena
    Golebiowski, Marek
    Malkowski, Piotr
    ANNALS OF TRANSPLANTATION, 2020, 25
  • [26] Arginine Metabolites as Biomarkers of Myocardial Ischaemia, Assessed with Cardiac Magnetic Resonance Imaging in Chronic Kidney Disease
    Shah, Ranjit J.
    Tommasi, Sara
    Faull, Randall
    Gleadle, Jonathan M.
    Mangoni, Arduino A.
    Selvanayagam, Joseph B.
    BIOMOLECULES, 2021, 11 (03) : 1 - 13
  • [27] Reduced oxygenation but not fibrosis defined by functional magnetic resonance imaging predicts the long-term progression of chronic kidney disease
    Sugiyama, Kei
    Inoue, Tsutomu
    Kozawa, Eito
    Ishikawa, Masahiro
    Shimada, Akira
    Kobayashi, Naoki
    Tanaka, Junji
    Okada, Hirokazu
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (06) : 964 - 970
  • [28] Amide proton transfer magnetic resonance imaging to evaluate renal impairment in patients with chronic kidney disease
    Ju, Ye
    Liu, Ailian
    Wang, Yue
    Chen, Lihua
    Wang, Nan
    Bu, Xinmiao
    Du, Changyu
    Jiang, Haoyang
    Wang, Jiazheng
    Lin, Liangjie
    MAGNETIC RESONANCE IMAGING, 2022, 87 : 177 - 182
  • [29] Identifying disease progression in chronic kidney disease using proton magnetic resonance spectroscopy
    Humphries, Tyrone L. R.
    Vesey, David A.
    Galloway, Graham J.
    Gobe, Glenda C.
    Francis, Ross S.
    PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2023, 134 : 52 - 64
  • [30] Evaluation of Renal Oxygenation and Hemodynamics in Patients with Chronic Kidney Disease by Blood Oxygenation Level-dependent Magnetic Resonance Imaging and Intrarenal Doppler Ultrasonography
    Yang, Jing
    Yang, Shuohui
    Xu, Yizeng
    Lu, Fang
    You, Lan
    He, Zheng
    Zhan, Songhua
    Ye, Chaoyang
    Liu, Mengxiao
    Fu, Caixia
    Wang, Chen
    NEPHRON, 2021, 145 (06) : 653 - 663